Your browser doesn't support javascript.
loading
Perception and safety analysis of COVID-19 vaccination in cancer patients: A multicenter, real-world study.
Lee, Kyoungmin; Park, In Hae; Oh, Sang Cheul; Seo, Jae Hong; Jeon, Min Ji; Yu, Eun Sang; Kim, Dae Sik; Choi, Chul Won; Lim, Ah-Reum; Hyun, Myung Han; Kim, Ju Won; Kim, Jwa Hoon; Choi, Yoon Ji; Lee, Soohyeon; Park, Kyong Hwa; Kim, Yeul Hong; Choi, Jung Yoon; Kim, Jung Sun; Lee, Se Ryeon; Sung, Hwa Jung; Kang, Eun Joo.
Affiliation
  • Lee K; Division of Hemato-Oncology, Department of Internal Medicine, Korea University College of Medicine, Korea University Guro Hospital, Seoul, Republic of Korea.
  • Park IH; Division of Hemato-Oncology, Department of Internal Medicine, Korea University College of Medicine, Korea University Guro Hospital, Seoul, Republic of Korea.
  • Oh SC; Division of Hemato-Oncology, Department of Internal Medicine, Korea University College of Medicine, Korea University Guro Hospital, Seoul, Republic of Korea.
  • Seo JH; Division of Hemato-Oncology, Department of Internal Medicine, Korea University College of Medicine, Korea University Guro Hospital, Seoul, Republic of Korea.
  • Jeon MJ; Division of Hemato-Oncology, Department of Internal Medicine, Korea University College of Medicine, Korea University Guro Hospital, Seoul, Republic of Korea.
  • Yu ES; Division of Hemato-Oncology, Department of Internal Medicine, Korea University College of Medicine, Korea University Guro Hospital, Seoul, Republic of Korea.
  • Kim DS; Division of Hemato-Oncology, Department of Internal Medicine, Korea University College of Medicine, Korea University Guro Hospital, Seoul, Republic of Korea.
  • Choi CW; Division of Hemato-Oncology, Department of Internal Medicine, Korea University College of Medicine, Korea University Guro Hospital, Seoul, Republic of Korea.
  • Lim AR; Division of Hemato-Oncology, Department of Internal Medicine, Korea University College of Medicine, Korea University Anam Hospital, Seoul, Republic of Korea.
  • Hyun MH; Division of Hemato-Oncology, Department of Internal Medicine, Korea University College of Medicine, Korea University Anam Hospital, Seoul, Republic of Korea.
  • Kim JW; Division of Hemato-Oncology, Department of Internal Medicine, Korea University College of Medicine, Korea University Anam Hospital, Seoul, Republic of Korea.
  • Kim JH; Division of Hemato-Oncology, Department of Internal Medicine, Korea University College of Medicine, Korea University Anam Hospital, Seoul, Republic of Korea.
  • Choi YJ; Division of Hemato-Oncology, Department of Internal Medicine, Korea University College of Medicine, Korea University Anam Hospital, Seoul, Republic of Korea.
  • Lee S; Division of Hemato-Oncology, Department of Internal Medicine, Korea University College of Medicine, Korea University Anam Hospital, Seoul, Republic of Korea.
  • Park KH; Division of Hemato-Oncology, Department of Internal Medicine, Korea University College of Medicine, Korea University Anam Hospital, Seoul, Republic of Korea.
  • Kim YH; Division of Hemato-Oncology, Department of Internal Medicine, Korea University College of Medicine, Korea University Anam Hospital, Seoul, Republic of Korea.
  • Choi JY; Division of Hemato-Oncology, Department of Internal Medicine, Korea University College of Medicine, Korea University Ansan Hospital, Ansan, Republic of Korea.
  • Kim JS; Division of Hemato-Oncology, Department of Internal Medicine, Korea University College of Medicine, Korea University Ansan Hospital, Ansan, Republic of Korea.
  • Lee SR; Division of Hemato-Oncology, Department of Internal Medicine, Korea University College of Medicine, Korea University Ansan Hospital, Ansan, Republic of Korea.
  • Sung HJ; Division of Hemato-Oncology, Department of Internal Medicine, Korea University College of Medicine, Korea University Ansan Hospital, Ansan, Republic of Korea.
  • Kang EJ; Division of Hemato-Oncology, Department of Internal Medicine, Korea University College of Medicine, Korea University Guro Hospital, Seoul, Republic of Korea.
Cancer Med ; 12(5): 5558-5568, 2023 03.
Article in En | MEDLINE | ID: mdl-36373165
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: COVID-19 Vaccines / COVID-19 / Neoplasms Type of study: Clinical_trials / Risk_factors_studies Limits: Female / Humans Language: En Journal: Cancer Med Year: 2023 Document type: Article Country of publication: United States
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: COVID-19 Vaccines / COVID-19 / Neoplasms Type of study: Clinical_trials / Risk_factors_studies Limits: Female / Humans Language: En Journal: Cancer Med Year: 2023 Document type: Article Country of publication: United States